A study supports previous findings that better-educated people have greater access to resources that promote healthy living, such as gym memberships or homes in neighborhoods that encourage walking. Researchers examined data from the U.S. National Health and Nutrition Examination Survey 2007-2012, and found adults with a college degree who were …
Read More »Yearly Archives: 2015
Novo Nordisk Gives Up on Victoza in T1D
Lackluster results for liraglutide as adjunct to insulin therapy: Novo Nordisk announced that it will not pursue an expanded indication for liraglutide (Victoza) as an add-on treatment to insulin for type 1 diabetes because of disappointing phase III trial results. The company released top-line results for the ADJUNCT ONE randomized …
Read More »Novo Moving Once-Daily Oral Version of Semaglutide Into Phase 3 Trials
They decided to initiate a phase 3a program with oral semaglutide; a once-daily oral formulation of the long-acting GLP-1 analogue semaglutide. The decision follows the encouraging results of the proof-of-concept phase 2 trial and the subsequent consultations with regulatory authorities. Novo Nordisk intends to initiate a global phase 3a program, …
Read More »My Diabetes Emergency Plan
What every patient needs to have to save their lives. For more information about preparing your diabetes supplies for an emergency, watch this “How to Pack Your Kit” video. A list of what you need from Eli Lilly — English version / Spanish version.
Read More »FDA Approves Synjardy
Empagliflozin/metformin is new combo medication for type 2 diabetes. More information coming in next week’s newsletter.
Read More »Old Shoes Best Fit When New Shoes Bring New Problems
Two weeks ago, a patient came in to the pharmacy complaining that his feet were burning and sore, and he was developing blisters on the top of his left foot. The patient had diabetes for about 13 years and had recently been running an A1c of 7.9. He was also …
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 3 of 6
George Bakris, MD, continues his discussion with Diabetes in Control Publisher Steve Freed. This week, the focus is why certain ethnic groups are more suscepticle to developing kidney disease, with or without diabetes. With the detection of the gene leading to kidney disease, more aggressive preventative treatment can be implemented …
Read More »Editor’s Note, DCMS #255
We have been at the U.S. Pro Challenge in Colorado this past week and after seven grueling days and 865 miles, Javier Megias of Team NovoNordisk was crowned Most Aggressive Rider. This rider, who lives with type 1 diabetes, is also the only rider who has managed to finish every …
Read More »New Insulin Now Available
New insulin now available: Humalog® 200 units/mL KwikPen®. See Product of the Week.
Read More »TeamNovoNordisk Rider interviews
KEVIN DE MESMAEKER 1. What does your morning include before a race? What do you eat for breakfast all the way until race start? I wake up and immediately check my blood sugar. Then I take my medication and usually go to breakfast. At breakfast, I like to eat oatmeal …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.